Longview News Journal • Internet • May 15, 2022, 1:50:50 PM
Continue to source
Open as PDF
Boehringer Ingelheim's latest investigational treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis
This article is only displayed as excerpt due to license restrictions

...Professor of Respiratory Medicine at the Università Cattolica del Sacro Cuore in Rome, Italy, and the Principal Investigator on the trial.

The primary endpoint of the trial was the change from baseline in forced...